Curriculum Pharma & Biotech Economics
Pharma & Biotech Economics
How medicines are invented, tested, made, regulated and sold - the R&D pipeline, clinical trials, biosimilars, contract manufacturing, India's API dependence, rare disease drugs, weight-loss drugs, pharma marketing and AI in drug discovery.
- How a New Drug Is Born The long, risky and expensive journey from a lab idea to an approved medicine, and why it shapes how drugs are priced. 📄 Read-aloud
- The Economics of Clinical Trials How clinical trial phases work, why they are so costly, and India's changing role as a trial destination. 📄 Read-aloud
- Biosimilars: Cheaper Copies of Biologic Drugs Why biologic medicines made from living cells are costly, how biosimilars bring competition, and how Indian firms like Biocon entered the market. 📄 Read-aloud
- Contract Manufacturing in Pharma How drug companies outsource research and production to contract firms, and why India hopes to win more of this business as buyers look beyond China. 📄 Read-aloud
- India's Dependence on Chinese Drug Ingredients Why India's large generic industry relies on China for active pharmaceutical ingredients, the risks this creates, and the push to make them at home. 📄 Read-aloud
- How Drugs Are Regulated in India How India's drug regulators approve medicines and inspect factories, why quality scandals damaged trust, and how rules were tightened. 📄 Read-aloud
- Pharma & Biotech Economics: Checkpoint 1 Quick checkpoint - five questions on drug development, trials, biosimilars, contract manufacturing and APIs. 5 questions
- The Business of Making Vaccines Why vaccines are a difficult business with high fixed costs and low prices, and how Indian makers built scale through tiered pricing and volume. 📄 Read-aloud
- Rare Diseases and Orphan Drugs Why treatments for rare diseases can cost crores of rupees, how incentives encourage their development, and how India supports patients. 📄 Read-aloud
- The Weight-Loss Drug Boom How GLP-1 drugs like semaglutide became some of the best-selling medicines in history, why they matter for India, and what happens when patents expire. 📄 Read-aloud
- Pharma Marketing and Doctors How drug companies promote brands to doctors, why this can raise costs for patients, and India's rules on gifts and incentives. 📄 Read-aloud
- Biotech Startups in India How India's biotech startups are funded and supported, why biotech is a hard business for young firms, and where new opportunities lie. 📄 Read-aloud
- AI and the Future of Drug Discovery How artificial intelligence is speeding up drug research, from protein structures to trial design, and a recap of pharma economics. 📄 Read-aloud